Tau phosphorylation: Physiological and pathological consequences

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1739, Issue 2, 2005, Pages 280-297

  Stoothoff, William H ^a   Johnson, Gail V W ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Filament; Kinase; Phosphatase; Phosphorylation; Tau; Tauopathy

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; CALCINEURIN; CHOLESTEROL; CYCLIN DEPENDENT KINASE 5; ENZYME INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LITHIUM CHLORIDE; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PRESENILIN 1; PROTEIN P25; PROTEIN P35; REELIN; TAU PROTEIN; TYROSINE; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ALZHEIMER DISEASE; CAENORHABDITIS ELEGANS; CELL CULTURE; DEGENERATIVE DISEASE; DROSOPHILA MELANOGASTER; ENZYME ACTIVITY; FROG; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENE OVEREXPRESSION; HIPPOCAMPUS; HUMAN; LAMPREY; LIFESPAN; MICROTUBULE; NERVE CELL DEGENERATION; NERVE FIBER GROWTH; NONHUMAN; ONSET AGE; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; RISK FACTOR; RISK REDUCTION; SEQUENCE HOMOLOGY; TRANSGENIC MOUSE; ZEBRA FISH;

ANIMALS; CASPASES; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN KINASES; TAU PROTEINS; TAUOPATHIES;

ANIMALIA;

EID: 10944227282     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2004.06.017     Document Type: Review

References (171)

1. N. Shahani, and R. Brandt Functions and malfunctions of the tau proteins Cell. Mol. Life Sci. 59 2002 1668 1680
2. M.D. Weingarten, A.H. Lockwood, S.Y. Hwo, and M.W. Kirschner A protein factor essential for microtubule assembly Proc. Natl. Acad. Sci. U. S. A. 72 1975 1858 1862
3. D.W. Cleveland, S.Y. Hwo, and M.W. Kirschner Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly J. Mol. Biol. 116 1977 227 247
4. G. Lindwall, and R.D. Cole Phosphorylation affects the ability of tau protein to promote microtubule assembly J. Biol. Chem. 259 1984 5301 5305
5. K.S. Kosik, C.L. Joachim, and D.J. Selkoe Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 83 1986 4044 4048
6. I. Grundke-Iqbal, K. Iqbal, Y.C. Tung, M. Quinlan, H.M. Wisniewski, and L.I. Binder Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology Proc. Natl. Acad. Sci. U. S. A. 83 1986 4913 4917
7. I. Grundke-Iqbal, K. Iqbal, M. Quinlan, Y.C. Tung, M.S. Zaidi, and H.M. Wisniewski Microtubule-associated protein tau. A component of Alzheimer paired helical filaments J. Biol. Chem. 261 1986 6084 6089
8. R.E. Tanzi, J.F. Gusella, P.C. Watkins, G.A. Bruns, P. St. George-Hyslop, M.L. Van Keuren, D. Patterson, S. Pagan, D.M. Kurnit, and R.L. Neve Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus Science 235 1987 880 884
9. P.H. St. George-Hyslop, R.E. Tanzi, R.J. Polinsky, J.L. Haines, L. Nee, P.C. Watkins, R.H. Myers, R.G. Feldman, D. Pollen, D. Drachman, J. Growdon, A. Bruni, J.-F. Foncin, D. Salmon, P. Frommelt, L. Amaducci, S. Sorbi, S. Piacentini, G.D. Stewart, W.J. Hobbs, P.M. Conneally, and J.F. Gusella The genetic defect causing familial Alzheimer's disease maps on chromosome 21 Science 235 1987 885 890
10. C.S. Atwood, M.E. Obrenovich, T. Liu, H. Chan, G. Perry, M.A. Smith, and R.N. Martins Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta Brain Res. Brain Res. Rev. 43 2003 1 16
11. M. Baker, J.B. Kwok, S. Kucera, R. Crook, M. Farrer, H. Houlden, A. Isaacs, S. Lincoln, L. Onstead, J. Hardy, L. Wittenberg, P. Dodd, S. Webb, N. Hayward, T. Tannenberg, A. Andreadis, M. Hallupp, P. Schofield, F. Dark, and M. Hutton Localization of frontotemporal dementia with parkinsonism in an Australian kindred to chromosome 17q21-22 Ann. Neurol. 42 1997 794 798
12. M. Hutton, C.L. Lendon, P. Rizzu, M. Baker, S. Froelich, H. Houlden, S. Pickering-Brown, S. Chakraverty, A. Isaacs, A. Grover, J. Hackett, J. Adamson, S. Lincoln, D. Dickson, P. Davies, R.C. Petersen, M. Stevens, E. de Graaff, E. Wauters, J. van Baren, M. Hillebrand, M. Joosse, J.M. Kwon, P. Nowotny, L.K. Che, J. Norton, J.C. Morris, L.A. Reed, J. Trojanowski, H. Basun, L. Lannfelt, M.L. Neystat, S. Fahn, F. Dark, T. Tanneberg, P.R. Dodd, N. Hayward, J.B. Kwok, P.R. Schofield, A. Andreadis, J. Snowden, D. Craufurd, D. Neary, F. Owen, B.A. Oostra, J. Hardy, A. Goate, J. VanSwieten, D. Mann, T. Lynch, and P. Heutink Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 Nature 393 1998 702 705
13. M.G. Spillantini, J.R. Murrell, M. Goedert, M.R. Farlow, A. Klug, and B. Ghetti Mutation in the tau gene in familial multiple system tauopathy with presenile dementia Proc. Natl. Acad. Sci. U. S. A. 95 1998 7737 7741
14. P. Poorkaj, T.D. Bird, E. Wijsman, E. Nemens, R.M. Garruto, L. Anderson, A. Andreadis, W.C. Wiederholt, M. Raskind, and G.D. Schellenberg Tau is a candidate gene for chromosome 17 frontotemporal dementia Ann. Neurol. 43 1998 815 825
15. D. Yancopoulou, and M.G. Spillantini Tau protein in familial and sporadic diseases Neuromolecular Med. 4 2003 37 48
16. C. Gally, and J.L. Bessereau [C. elegans: of neurons and genes] Med. Sci. (Paris) 19 2003 725 734
17. B.C. Kraemer, B. Zhang, J.B. Leverenz, J.H. Thomas, J.Q. Trojanowski, and G.D. Schellenberg Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy Proc. Natl. Acad. Sci. U. S. A. 100 2003 9980 9985
18. H. Schmidt, C. Rickert, T. Bossing, O. Vef, J. Urban, and G.M. Technau The embryonic central nervous system lineages of Drosophila melanogaster: II. Neuroblast lineages derived from the dorsal part of the neuroectoderm Dev. Biol. 189 1997 186 204
19. T. Bossing, G. Udolph, C.Q. Doe, and G.M. Technau The embryonic central nervous system lineages of Drosophila melanogaster: I. Neuroblast lineages derived from the ventral half of the neuroectoderm Dev. Biol. 179 1996 41 64
20. V. Cambiazo, M. Gonzalez, and R.B. Maccioni DMAP-85: a tau-like protein from Drosophila melanogaster larvae J. Neurochem. 64 1995 1288 1297
21. C.W. Wittmann, M.F. Wszolek, J.M. Shulman, P.M. Salvaterra, J. Lewis, M. Hutton, and M.B. Feany Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles Science 293 2001 711 714
22. D.W. Williams, M. Tyrer, and D. Shepherd Tau and tau reporters disrupt central projections of sensory neurons in Drosophila J. Comp. Neurol. 428 2000 630 640
23. G.R. Jackson, M. Wiedau-Pazos, T.K. Sang, N. Wagle, C.A. Brown, S. Massachi, and D.H. Geschwind Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila Neuron 34 2002 509 519
24. R.S. Jope, and G.V. Johnson The glamour and gloom of glycogen synthase kinase 3 (GSK3) Trends Biol. Sci. 29 2004 95 102
25. J.M. Shulman, and M.B. Feany Genetic modifiers of tauopathy in Drosophila Genetics 165 2003 1233 1242
26. B.H. Anderton, J. Betts, W.P. Blackstock, J.P. Brion, S. Chapman, J. Connell, R. Dayanandan, J.M. Gallo, G. Gibb, D.P. Hanger, M. Hutton, E. Kardalinou, K. Leroy, S. Lovestone, T. Mack, C.H. Reynolds, and M. Van Slegtenhorst Sites of phosphorylation in tau and factors affecting their regulation Biochem. Soc. Symp. 2001 73 80
27. J. Wang, X. Wang, R. Liu, Q. Wang, I. Grundke-Iqbal, and K. Iqbal In vitro analysis of tau phosphorylation sites and its biological activity Chin. Med. Sci. J. 17 2002 13 16
28. H.Y. Wang, W. Li, N.J. Benedetti, and D.H. Lee Alpha 7 nicotinic acetylcholine receptors mediate beta-amyloid peptide-induced tau protein phosphorylation J. Biol. Chem. 278 2003 31547 31553
29. G.V. Johnson, and J.A. Hartigan Tau protein in normal and Alzheimer's disease brain: an update J. Alzheimer's Dis. 1 1999 329 351
30. D.H. Geschwind Tau phosphorylation, tangles, and neurodegeneration: the chicken or the egg? Neuron 40 2003 457 460
31. T.G. Deliagina, P.V. Zelenin, and G.N. Orlovsky Encoding and decoding of reticulospinal commands Brain Res. Brain Res. Rev. 40 2002 166 177
32. G.F. Hall, J. Yao, and G. Lee Human tau becomes phosphorylated and forms filamentous deposits when overexpressed in lamprey central neurons in situ Proc. Natl. Acad. Sci. U. S. A. 94 1997 4733 4738
33. G.F. Hall, V.M. Lee, G. Lee, and J. Yao Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy Am. J. Pathol. 158 2001 235 246
34. G.F. Hall PHF-tau from Alzheimer brain is rapidly dephosphorylated and degraded when injected into neurons in situ J. Alzheimer's Dis. 1 1999 379 386
35. G.F. Hall, S. Lee, and J. Yao Neurofibrillary degeneration can be arrested in an in vivo cellular model of human tauopathy by application of a compound which inhibits tau filament formation in vitro J. Mol. Neurosci. 19 2002 253 260
36. J.T. Shin, and M.C. Fishman From Zebrafish to human: modular medical models Annu. Rev. Genomics Hum. Genet. 3 2002 311 340
37. A.C. Ward, and G.J. Lieschke The zebrafish as a model system for human disease Front. Biosci. 7 2002 d827 d833
38. G.E. Ackermann, and B.H. Paw Zebrafish: a genetic model for vertebrate organogenesis and human disorders Front. Biosci. 8 2003 d1227 d1253
39. H.G. Tomasiewicz, D.B. Flaherty, J.P. Soria, and J.G. Wood Transgenic zebrafish model of neurodegeneration J. Neurosci. Res. 70 2002 734 745
40. P. Delobel, S. Flament, M. Hamdane, C. Mailliot, A.V. Sambo, S. Begard, N. Sergeant, A. Delacourte, J.P. Vilain, and L. Buee Abnormal tau phosphorylation of the Alzheimer-type also occurs during mitosis J. Neurochem. 83 2002 412 420
41. P. Delobel, S. Flament, M. Hamdane, A. Delacourte, J.P. Vilain, and L. Buee Modelling Alzheimer-specific abnormal tau phosphorylation independently of GSK3beta and PKA kinase activities FEBS Lett. 516 2002 151 155
42. P. Delobel, S. Flament, M. Hamdane, R. Jakes, A. Rousseau, A. Delacourte, J.P. Vilain, M. Goedert, and L. Buee Functional characterization of FTDP-17 tau gene mutations through their effects on Xenopus oocyte maturation J. Biol. Chem. 277 2002 9199 9205
43. Y. Yang, D.S. Geldmacher, and K. Herrup DNA replication precedes neuronal cell death in Alzheimer's disease J. Neurosci. 21 2001 2661 2668
44. Y. Yang, E.J. Mufson, and K. Herrup Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease J. Neurosci. 23 2003 2557 2563
45. S.H. Lin, Z.Z. Chong, and K. Maiese Cell cycle induction in post-mitotic neurons proceeds in concert with the initial phase of programmed cell death in rat Neurosci. Lett. 310 2001 173 177
46. R.S. Freeman, S. Estus, and E.M. Johnson Jr. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of Cyclin D1 during programmed cell death Neuron 12 1994 343 355
47. C. Liu, Y. Li, M. Semenov, C. Han, G.H. Baeg, Y. Tan, Z. Zhang, X. Lin, and X. He Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism Cell 108 2002 837 847
48. A.J. Harwood Regulation of GSK-3: a cellular multiprocessor Cell 105 2001 821 824
49. P.J. Lu, G. Wulf, X.Z. Zhou, P. Davies, and K.P. Lu The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein Nature 399 1999 784 788
50. I. Vincent, G. Jicha, M. Rosado, and D.W. Dickson Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain J. Neurosci. 17 1997 3588 3598
51. X.Z. Zhou, O. Kops, A. Werner, P.J. Lu, M. Shen, G. Stoller, G. Kullertz, M. Stark, G. Fischer, and K.P. Lu Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins Mol. Cell 6 2000 873 883
52. S. Frame, P. Cohen, and R.M. Biondi A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation Mol. Cell 7 2001 1321 1327
53. R. Dajani, E. Fraser, S.M. Roe, N. Young, V. Good, T.C. Dale, and L.H. Pearl Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition Cell 105 2001 721 732
54. J.H. Cho, and G.V. Johnson Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding J. Biol. Chem. 278 2003 187 193
55. J.H. Cho, and G.V. Johnson Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules J. Neurochem. 88 2004 349 358
56. D.C. David, R. Layfield, L. Serpell, Y. Narain, M. Goedert, and M.G. Spillantini Proteasomal degradation of tau protein J. Neurochem. 83 2002 176 185
57. O. Goldbaum, M. Oppermann, M. Handschuh, D. Dabir, B. Zhang, M.S. Forman, J.Q. Trojanowski, V.M. Lee, and C. Richter-Landsberg Proteasome inhibition stabilizes tau inclusions in oligodendroglial cells that occur after treatment with okadaic acid J. Neurosci. 23 2003 8872 8880
58. H. Shimura, D. Schwartz, S.P. Gygi, and K.S. Kosik CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival J. Biol. Chem. 279 2004 4869 4876
59. M. Hong, and V.M. Lee Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons J. Biol. Chem. 272 1997 19547 19553
60. M. Lesort, and G.V. Johnson Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons Neuroscience 99 2000 305 316
61. M. Lesort, R.S. Jope, and G.V. Johnson Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase J. Neurochem. 72 1999 576 584
62. T. Ishii, H. Furuoka, Y. Muroi, and M. Nishimura Inactivation of integrin-linked kinase induces aberrant tau phosphorylation via sustained activation of glycogen synthase kinase 3beta in N1E-115 neuroblastoma cells J. Biol. Chem. 278 2003 26970 26975
63. J. Mills, M. Digicaylioglu, A.T. Legg, C.E. Young, S.S. Young, A.M. Barr, L. Fletcher, T.P. O'Connor, and S. Dedhar Role of integrin-linked kinase in nerve growth factor-stimulated neurite outgrowth J. Neurosci. 23 2003 1638 1648
64. J.A. Hartigan, and G.V. Johnson Transient increases in intracellular calcium result in prolonged site-selective increases in tau phosphorylation through a glycogen synthase kinase 3beta-dependent pathway J. Biol. Chem. 274 1999 21395 21401
65. A. Cole, S. Frame, and P. Cohen Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event Biochem. J. 377 2004 249 255
66. A. Mudher, S. Chapman, J. Richardson, A. Asuni, G. Gibb, C. Pollard, R. Killick, T. Iqbal, L. Raymond, I. Varndell, P. Sheppard, A. Makoff, E. Gower, P.E. Soden, P. Lewis, M. Murphy, T.E. Golde, H.T. Rupniak, B.H. Anderton, and S. Lovestone Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase J. Neurosci. 21 2001 4987 4995
67. L. Li, H. Yuan, C.D. Weaver, J. Mao, G.H. Farr III, D.J. Sussman, J. Jonkers, D. Kimelman, and D. Wu Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1 EMBO J. 18 1999 4233 4240
68. R. Godemann, J. Biernat, E. Mandelkow, and E.M. Mandelkow Phosphorylation of tau protein by recombinant GSK-3beta: pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain FEBS Lett. 454 1999 157 164
69. A.A. Culbert, M.J. Brown, S. Frame, T. Hagen, D.A. Cross, B. Bax, and A.D. Reith GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity FEBS Lett. 507 2001 288 294
70. W.H. Stoothoff, C.D. Bailey, K. Mi, S.C. Lin, and G.V. Johnson Axin negatively affects tau phosphorylation by glycogen synthase kinase 3beta J. Neurochem. 83 2002 904 913
71. S. Sato, Y. Tatebayashi, T. Akagi, D.H. Chui, M. Murayama, T. Miyasaka, E. Planel, K. Tanemura, X. Sun, T. Hashikawa, K. Yoshioka, K. Ishiguro, and A. Takashima Aberrant tau phosphorylation by glycogen synthase kinase-3beta and JNK3 induces oligomeric tau fibrils in COS-7 cells J. Biol. Chem. 277 2002 42060 42065
72. D.S. Smith, and L.H. Tsai Cdk5 behind the wheel: a role in trafficking and transport? Trends Cell Biol. 12 2002 28 36
73. M. Hamdane, A.V. Sambo, P. Delobel, S. Begard, A. Violleau, A. Delacourte, P. Bertrand, J. Benavides, and L. Buee Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex J. Biol. Chem. 278 2003 34026 34034
74. S.B. Shelton, and G.V. Johnson Cyclin-dependent kinase-5 in neurodegeneration J. Neurochem. 88 2004 1313 1326
75. G.N. Patrick, L. Zukerberg, M. Nikolic, S. de la Monte, P. Dikkes, and L.H. Tsai Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration Nature 402 1999 615 622
76. M.S. Lee, Y.T. Kwon, M. Li, J. Peng, R.M. Friedlander, and L.H. Tsai Neurotoxicity induces cleavage of p35 to p25 by calpain Nature 405 2000 360 364
77. K.C. Nguyen, J.L. Rosales, M. Barboza, and K.Y. Lee Controversies over p25 in Alzheimer's disease J. Alzheimer's Dis. 4 2002 123 126
78. A. Tandon, H. Yu, L. Wang, E. Rogaeva, C. Sato, M.A. Chishti, T. Kawarai, H. Hasegawa, F. Chen, P. Davies, P.E. Fraser, D. Westaway, and P.H. St. George-Hyslop Brain levels of CDK5 activator p25 are not increased in Alzheimer's or other neurodegenerative diseases with neurofibrillary tangles J. Neurochem. 86 2003 572 581
79. B.C. Yoo, and G. Lubec p25 protein in neurodegeneration Nature 411 2001 763 764 (discussion 764-765)
80. Q. Tian, and J. Wang Role of serine/threonine protein phosphatase in Alzheimer's disease NeuroSignals 11 2002 262 269
81. H. Liao, Y. Li, D.L. Brautigan, and G.G. Gundersen Protein phosphatase 1 is targeted to microtubules by the microtubule-associated protein Tau J. Biol. Chem. 273 1998 21901 21908
82. C.X. Gong, F. Liu, G. Wu, S. Rossie, J. Wegiel, L. Li, I. Grundke-Iqbal, and K. Iqbal Dephosphorylation of microtubule-associated protein tau by protein phosphatase 5 J. Neurochem. 88 2004 298 310
83. E. Sontag, V. Nunbhakdi-Craig, G. Lee, G.S. Bloom, and M.C. Mumby Regulation of the phosphorylation state and microtubule-binding activity of tau by protein phosphatase 2A Neuron 17 1996 1201 1207
84. E. Sontag, V. Nunbhakdi-Craig, G. Lee, R. Brandt, C. Kamibayashi, J. Kuret, C.L. White III, M.C. Mumby, and G.S. Bloom Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies J. Biol. Chem. 274 1999 25490 25498
85. N.L. Daly, R. Hoffmann, L. Otvos Jr., and D.J. Craik Role of phosphorylation in the conformation of tau peptides implicated in Alzheimer's disease Biochemistry 39 2000 9039 9046
86. M. Goedert, S. Satumtira, R. Jakes, M.J. Smith, C. Kamibayashi, C.L. White 3rd, and E. Sontag Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations J. Neurochem. 75 2000 2155 2162
87. G. Lee, R. Thangavel, V.M. Sharma, J.M. Litersky, K. Bhaskar, S.M. Fang, L.H. Do, A. Andreadis, G. Van Hoesen, and H. Ksiezak-Reding Phosphorylation of tau by fyn, implications for Alzheimer's diseas J. Neurosci. 24 2004 2304 2312
88. G. Lee, S.T. Newman, D.L. Gard, H. Band, and G. Panchamoorthy Tau interacts with src-family non-receptor tyrosine kinases J. Cell Sci. 111 Pt. 21 1998 3167 3177
89. R. Williamson, T. Scales, B.R. Clark, G. Gibb, C.H. Reynolds, S. Kellie, I.N. Bird, I.M. Varndell, P.W. Sheppard, I. Everall, and B.H. Anderton Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases J. Neurosci. 22 2002 10 20
90. C. Klein, E.M. Kramer, A.M. Cardine, B. Schraven, R. Brandt, and J. Trotter Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau J. Neurosci. 22 2002 698 707
91. M. Burns, and K. Duff Cholesterol in Alzheimer's disease and tauopathy Ann. N. Y. Acad. Sci. 977 2002 367 375
92. H. Jick, G.L. Zornberg, S.S. Jick, S. Seshadri, and D.A. Drachman Statins and the risk of dementia Lancet 356 2000 1627 1631
93. I.A. Auer, M.L. Schmidt, V.M. Lee, B. Curry, K. Suzuki, R.W. Shin, P.G. Pentchev, E.D. Carstea, and J.Q. Trojanowski Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease Acta Neuropathol. (Berl.) 90 1995 547 551
94. B. Bu, J. Li, P. Davies, and I. Vincent Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model J. Neurosci. 22 2002 6515 6525
95. Q.W. Fan, W. Yu, T. Senda, K. Yanagisawa, and M. Michikawa Cholesterol-dependent modulation of tau phosphorylation in cultured neurons J. Neurochem. 76 2001 391 400
96. V. Meske, F. Albert, D. Richter, J. Schwarze, and T.G. Ohm Blockade of HMG-CoA reductase activity causes changes in microtubule-stabilizing protein tau via suppression of geranylgeranylpyrophosphate formation: implications for Alzheimer's disease Eur. J. Neurosci. 17 2003 93 102
97. K. Fassbender, M. Simons, C. Bergmann, M. Stroick, D. Lutjohann, P. Keller, H. Runz, S. Kuhl, T. Bertsch, K. von Bergmann, M. Hennerici, K. Beyreuther, and T. Hartmann Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo Proc. Natl. Acad. Sci. U. S. A. 98 2001 5856 5861
98. M. Simons, P. Keller, B. De Strooper, K. Beyreuther, C.G. Dotti, and K. Simons Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons Proc. Natl. Acad. Sci. U. S. A. 95 1998 6460 6464
99. J. Herz The LDL receptor gene family: (un)expected signal transducers in the brain Neuron 29 2001 571 581
100. T. Hiesberger, M. Trommsdorff, B.W. Howell, A. Goffinet, M.C. Mumby, J.A. Cooper, and J. Herz Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation Neuron 24 1999 481 489
101. U. Beffert, G. Morfini, H.H. Bock, H. Reyna, S.T. Brady, and J. Herz Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta J. Biol. Chem. 277 2002 49958 49964
102. K.S. Kosik, L.D. Orecchio, S. Bakalis, and R.L. Neve Developmentally regulated expression of specific tau sequences Neuron 2 1989 1389 1397
103. C.A. Walsh, and A.M. Goffinet Potential mechanisms of mutations that affect neuronal migration in man and mouse Curr. Opin. Genet. Dev. 10 2000 270 274
104. A. Caceres, and K.S. Kosik Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons Nature 343 1990 461 463
105. A. Caceres, S. Potrebic, and K.S. Kosik The effect of tau antisense oligonucleotides on neurite formation of cultured cerebellar macroneurons J. Neurosci. 11 1991 1515 1523
106. J. Biernat, and E.M. Mandelkow The development of cell processes induced by tau protein requires phosphorylation of serine 262 and 356 in the repeat domain and is inhibited by phosphorylation in the proline-rich domains Mol. Biol. Cell 10 1999 727 740
107. J. Biernat, Y.Z. Wu, T. Timm, Q. Zheng-Fischhofer, E. Mandelkow, L. Meijer, and E.M. Mandelkow Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity Mol. Biol. Cell 13 2002 4013 4028
108. C.L. Sayas, J. Avila, and F. Wandosell Glycogen synthase kinase-3 is activated in neuronal cells by Galpha12 and Galpha13 by Rho-independent and Rho-dependent mechanisms J. Neurosci. 22 2002 6863 6875
109. C.L. Sayas, J. Avila, and F. Wandosell Regulation of neuronal cytoskeleton by lysophosphatidic acid: role of GSK-3 Biochim. Biophys. Acta 1582 2002 144 153
110. J. Busciglio, A. Lorenzo, J. Yeh, and B.A. Yankner beta-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding Neuron 14 1995 879 888
111. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
112. B. De Strooper Aph-1, Pen-2, and nicastrin with presenilin generate an active gamma-secretase complex Neuron 38 2003 9 12
113. G. Pigino, A. Pelsman, H. Mori, and J. Busciglio Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation J. Neurosci. 21 2001 834 842
114. A. Ferrari, F. Hoerndli, T. Baechi, R.M. Nitsch, and J. Gotz beta-Amyloid induces paired helical filament-like tau filaments in tissue culture J. Biol. Chem. 278 2003 40162 40168
115. A. Abraha, N. Ghoshal, T.C. Gamblin, V. Cryns, R.W. Berry, J. Kuret, and L.I. Binder C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease J. Cell Sci. 113 Pt. 21 2000 3737 3745
116. L. Fasulo, G. Ugolini, M. Visintin, A. Bradbury, C. Brancolini, V. Verzillo, M. Novak, and A. Cattaneo The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis J. Neurochem. 75 2000 624 633
117. R.W. Berry, A. Abraha, S. Lagalwar, N. LaPointe, T.C. Gamblin, V.L. Cryns, and L.I. Binder Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment Biochemistry 42 2003 8325 8331
118. T.C. Gamblin, F. Chen, A. Zambrano, A. Abraha, S. Lagalwar, A.L. Guillozet, M. Lu, Y. Fu, F. Garcia-Sierra, N. LaPointe, R. Miller, R.W. Berry, L.I. Binder, and V.L. Cryns Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 100 2003 10032 10037
119. E.M. Ingram, and M.G. Spillantini Tau gene mutations: dissecting the pathogenesis of FTDP-17 Trends Mol. Med. 8 2002 555 562
120. N. Matsumura, T. Yamazaki, and Y. Ihara Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) Am. J. Pathol. 154 1999 1649 1656
121. V. Vogelsberg-Ragaglia, J. Bruce, C. Richter-Landsberg, B. Zhang, M. Hong, J.Q. Trojanowski, and V.M. Lee Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells Mol. Biol. Cell 11 2000 4093 4104
122. R. Dayanandan, M. Van Slegtenhorst, T.G. Mack, L. Ko, S.H. Yen, K. Leroy, J.P. Brion, B.H. Anderton, M. Hutton, and S. Lovestone Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation FEBS Lett. 446 1999 228 232
123. T.G. Mack, R. Dayanandan, M. Van Slegtenhorst, A. Whone, M. Hutton, S. Lovestone, and B.H. Anderton Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells Neuroscience 108 2001 701 712
124. M. DeTure, L.W. Ko, C. Easson, and S.H. Yen Tau assembly in inducible transfectants expressing wild-type or FTDP-17 tau Am. J. Pathol. 161 2002 1711 1722
125. P.K. Krishnamurthy, and G.V. Johnson Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model J. Biol. Chem. 2003 7893 7900
126. J. Liang, J. Zubovitz, T. Petrocelli, R. Kotchetkov, M.K. Connor, K. Han, J.H. Lee, S. Ciarallo, C. Catzavelos, R. Beniston, E. Franssen, and J.M. Slingerland PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest Nat. Med. 8 2002 1153 1160
127. J. Leger, M. Kempf, G. Lee, and R. Brandt Conversion of serine to aspartate imitates phosphorylation-induced changes in the structure and function of microtubule-associated protein tau J. Biol. Chem. 272 1997 8441 8446
128. J. Eidenmuller, T. Fath, T. Maas, M. Pool, E. Sontag, and R. Brandt Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein Biochem. J. 357 2001 759 767
129. T. Fath, J. Eidenmuller, and R. Brandt Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease J. Neurosci. 22 2002 9733 9741
130. G.V. Johnson, and C.D. Bailey Tau, where are we now? J. Alzheimer's Dis. 4 2002 375 398
131. K. Baumann, E.M. Mandelkow, J. Biernat, H. Piwnica-Worms, and E. Mandelkow Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5 FEBS Lett. 336 1993 417 424
132. S. Kobayashi, K. Ishiguro, A. Omori, M. Takamatsu, M. Arioka, K. Imahori, and T. Uchida A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule FEBS Lett. 335 1993 171 175
133. M.K. Ahlijanian, N.X. Barrezueta, R.D. Williams, A. Jakowski, K.P. Kowsz, S. McCarthy, T. Coskran, A. Carlo, P.A. Seymour, J.E. Burkhardt, R.B. Nelson, and J.D. McNeish Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5 Proc. Natl. Acad. Sci. U. S. A. 97 2000 2910 2915
134. F. Bian, R. Nath, G. Sobocinski, R.N. Booher, W.J. Lipinski, M.J. Callahan, A. Pack, K.K. Wang, and L.C. Walker Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice J. Comp. Neurol. 446 2002 257 266
135. H. Patzke, U. Maddineni, R. Ayala, M. Morabito, J. Volker, P. Dikkes, M.K. Ahlijanian, and L.H. Tsai Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene J. Neurosci. 23 2003 2769 2778
136. C. Van den Haute, K. Spittaels, J. Van Dorpe, R. Lasrado, K. Vandezande, I. Laenen, H. Geerts, and F. Van Leuven Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice Neurobiol. Dis. 8 2001 32 44
137. M. Angelo, F. Plattner, E.E. Irvine, and K.P. Giese Improved reversal learning and altered fear conditioning in transgenic mice with regionally restricted p25 expression Eur. J. Neurosci. 18 2003 423 431
138. J.L. Hallows, K. Chen, R.A. DePinho, and I. Vincent Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice J. Neurosci. 23 2003 10633 10644
139. J.C. Cruz, H.C. Tseng, J.A. Goldman, H. Shih, and L.H. Tsai Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles Neuron 40 2003 471 483
140. W. Noble, V. Olm, K. Takata, E. Casey, O. Mary, J. Meyerson, K. Gaynor, J. LaFrancois, L. Wang, T. Kondo, P. Davies, M. Burns, Veeranna, R. Nixon, D. Dickson, Y. Matsuoka, M. Ahlijanian, L.F. Lau, and K. Duff Cdk5 is a key factor in tau aggregation and tangle formation in vivo Neuron 38 2003 555 565
141. K. Spittaels, C. Van den Haute, J. Van Dorpe, D. Terwel, K. Vandezande, R. Lasrado, K. Bruynseels, M. Irizarry, M. Verhoye, J. Van Lint, J.R. Vandenheede, D. Ashton, M. Mercken, R. Loos, B. Hyman, A. Van der Linden, H. Geerts, and F. Van Leuven Neonatal neuronal overexpression of glycogen synthase kinase-3 beta reduces brain size in transgenic mice Neuroscience 113 2002 797 808
142. K. Tilleman, I. Stevens, K. Spittaels, C.V. Haute, S. Clerens, G. Van Den Bergh, H. Geerts, F. Van Leuven, F. Vandesande, and L. Moens Differential expression of brain proteins in glycogen synthase kinase-3 transgenic mice: a proteomics point of view Proteomics 2 2002 94 104
143. J.J. Lucas, F. Hernandez, P. Gomez-Ramos, M.A. Moran, R. Hen, and J. Avila Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice EMBO J. 20 2001 27 39
144. F. Hernandez, J. Borrell, C. Guaza, J. Avila, and J.J. Lucas Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments J. Neurochem. 83 2002 1529 1533
145. T. Ishizawa, N. Sahara, K. Ishiguro, J. Kersh, E. McGowan, J. Lewis, M. Hutton, D.W. Dickson, and S.H. Yen Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice Am. J. Pathol. 163 2003 1057 1067
146. R. Nuydens, G. Van Den Kieboom, C. Nolten, C. Verhulst, P. Van Osta, K. Spittaels, C. Van den Haute, E. De Feyter, H. Geerts, and F. Van Leuven Coexpression of GSK-3beta corrects phenotypic aberrations of dorsal root ganglion cells, cultured from adult transgenic mice overexpressing human protein tau Neurobiol. Dis. 9 2002 38 48
147. K. Spittaels, C. Van den Haute, J. Van Dorpe, H. Geerts, M. Mercken, K. Bruynseels, R. Lasrado, K. Vandezande, I. Laenen, T. Boon, J. Van Lint, J. Vandenheede, D. Moechars, R. Loos, and F. Van Leuven Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice J. Biol. Chem. 275 2000 41340 41349
148. M. Perez, F. Hernandez, F. Lim, J. Diaz-Nido, and J. Avila Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model J. Alzheimer's Dis. 5 2003 301 308
149. R.S. Jope Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes Trends Pharmacol. Sci. 24 2003 441 443
150. G.A. Higgins, and H. Jacobsen Transgenic mouse models of Alzheimer's disease: phenotype and application Behav. Pharmacol. 14 2003 419 438
151. M. Kobayashi, K. Ishiguro, Y. Katoh-Fukui, M. Yokoyama, and S.C. Fujita Phosphorylation state of tau in the hippocampus of apolipoprotein E4 and E3 knock-in mice NeuroReport 14 2003 699 702
152. F.M. Harris, W.J. Brecht, Q. Xu, I. Tesseur, L. Kekonius, T. Wyss-Coray, J.D. Fish, E. Masliah, P.C. Hopkins, K. Scearce-Levie, K.H. Weisgraber, L. Mucke, R.W. Mahley, and Y. Huang Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice Proc. Natl. Acad. Sci. U. S. A. 100 2003 10966 10971
153. G.M. Gibb, J. Pearce, J.C. Betts, S. Lovestone, M.M. Hoffmann, W. Maerz, W.P. Blackstock, and B.H. Anderton Differential effects of apolipoprotein E
154. Y. Huang, X.Q. Liu, T. Wyss-Coray, W.J. Brecht, D.A. Sanan, and R.W. Mahley Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons Proc. Natl. Acad. Sci. U. S. A. 98 2001 8838 8843
155. N. Ohkubo, Y.D. Lee, A. Morishima, T. Terashima, S. Kikkawa, M. Tohyama, M. Sakanaka, J. Tanaka, N. Maeda, M.P. Vitek, and N. Mitsuda Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade FASEB J. 17 2003 295 297
156. G. Xu, V. Gonzales, and D.R. Borchelt Abeta deposition does not cause the aggregation of endogenous tau in transgenic mice Alzheimer Dis. Assoc. Disord. 16 2002 196 201
157. Y. Tomidokoro, Y. Harigaya, E. Matsubara, M. Ikeda, T. Kawarabayashi, T. Shirao, K. Ishiguro, K. Okamoto, S.G. Younkin, and M. Shoji Brain Abeta amyloidosis in APPsw mice induces accumulation of presenilin-1 and tau J. Pathol. 194 2001 500 506
158. M.A. Kurt, D.C. Davies, M. Kidd, K. Duff, and D.R. Howlett Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes Neurobiol. Dis. 14 2003 89 97
159. V. Blanchard, S. Moussaoui, C. Czech, N. Touchet, B. Bonici, M. Planche, T. Canton, I. Jedidi, M. Gohin, O. Wirths, T.A. Bayer, D. Langui, C. Duyckaerts, G. Tremp, and L. Pradier Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice Exp. Neurol. 184 2003 247 263
160. G. Pigino, G. Morfini, A. Pelsman, M.P. Mattson, S.T. Brady, and J. Busciglio Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport J. Neurosci. 23 2003 4499 4508
161. J. Lewis, D.W. Dickson, W.L. Lin, L. Chisholm, A. Corral, G. Jones, S.H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP Science 293 2001 1487 1491
162. J. Gotz, F. Chen, J. van Dorpe, and R.M. Nitsch Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils Science 293 2001 1491 1495
163. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, R. Kayed, R. Metherate, M.P. Mattson, Y. Akbari, and F.M. LaFerla Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction Neuron 39 2003 409 421
164. A. Boutajangout, M. Authelet, V. Blanchard, N. Touchet, G. Tremp, L. Pradier, and J.P. Brion Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1 Neurobiol. Dis. 15 2004 47 60
165. S. Oddo, A. Caccamo, M. Kitazawa, B.P. Tseng, and F.M. LaFerla Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease Neurobiol. Aging 24 2003 1063 1070
166. H. Arai, K. Ishiguro, H. Ohno, M. Moriyama, N. Itoh, N. Okamura, T. Matsui, Y. Morikawa, E. Horikawa, H. Kohno, H. Sasaki, and K. Imahori CSF phosphorylated tau protein and mild cognitive impairment: a prospective study Exp. Neurol. 166 2000 201 203
167. T.W. Mitchell, E.J. Mufson, J.A. Schneider, E.J. Cochran, J. Nissanov, L.Y. Han, J.L. Bienias, V.M. Lee, J.Q. Trojanowski, D.A. Bennett, and S.E. Arnold Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease Ann. Neurol. 51 2002 182 189
168. N. Ghoshal, F. Garcia-Sierra, J. Wuu, S. Leurgans, D.A. Bennett, R.W. Berry, and L.I. Binder Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease Exp. Neurol. 177 2002 475 493
169. M. Rapoport, H.N. Dawson, L.I. Binder, M.P. Vitek, and A. Ferreira Tau is essential to beta-amyloid-induced neurotoxicity Proc. Natl. Acad. Sci. U. S. A. 99 2002 6364 6369
170. J. Hardy The relationship between amyloid and tau J. Mol. Neurosci. 20 2003 203 206
171. M.P. Mattson Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease J. Neurovirol. 8 2002 539 550